New Model for Outpatient Induction Chemotherapy for AML and MDS Explored
May 28th 2014Although many patients with cancer now receive chemotherapy as outpatients, most cancer treatment centers do not extend this practice to patients with acute myeloid leukemia (AML) or advanced myelodysplastic syndromes (MDS) who are receiving initial intensive induction therapy.
Read More